You have 9 free searches left this month | for more free features.

Existing Medicines

Showing 1 - 25 of 6,094

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Optimising Pharmacist-led Medication Reviews in Primary Care

Not yet recruiting
  • ALL, Adult
  • Medication review
  • (no location specified)
Jun 22, 2023

Hypertension Trial in United Kingdom (OE 10 mg amlodipine besylate tablet, OE 200 mg celecoxib capsule, Matched for OE

Completed
  • Hypertension
  • OE 10 mg amlodipine besylate tablet
  • +3 more
  • Bath, United Kingdom
  • +8 more
Sep 27, 2019

Avelumab First-Line Maintenance in Canadian People With Advanced

Not yet recruiting
  • Urinary Bladder Neoplasms
  • +3 more
  • Avelumab first-line maintenance
  • Mississauga, Ontario, Canada
    Bayshore Specialty Rx
Jan 24, 2023

Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

Terminated
  • Head and Neck Cancer
  • +7 more
  • Tumor Profiling
  • Scottsdale, Arizona
  • +2 more
Dec 2, 2022

Epilepsy Trial in Dhulikhel (Sodium valproate and valproic acid extended release tablet)

Not yet recruiting
  • Epilepsy
  • Sodium valproate and valproic acid extended release tablet
  • Dhulikhel, Bagmati, Nepal
  • +1 more
Dec 6, 2022

Pneumonia, COPD Asthma, COPD Exacerbation Trial in Istanbul (Intervention groups)

Completed
  • Pneumonia
  • +2 more
  • Intervention groups
  • Istanbul, Turkey
    Bezmialem Vakif University
Oct 3, 2022

Type 2 Diabetes Treated With Insulin, Hypoglycemia, Primary Health Care Trial in United States (Conversation Aid, Attention

Recruiting
  • Type 2 Diabetes Treated With Insulin
  • +3 more
  • Conversation Aid
  • Attention Control Educational Handout
  • San Francisco, California
  • +3 more
Jan 27, 2023

Bacterial Infections Trial in Quezon City (Monolaurin, Mupirocin ointment)

Completed
  • Bacterial Infections
  • Quezon City, NCR, Philippines
    V. Luna Medical Center
Sep 21, 2023

Lung Cancer Patient ExperiEnce in the Real-World Setting

Recruiting
  • Lung Cancer Patients
  • Caregivers
  • There are no interventions in this study. All participants complete online surveys.
  • Bethesda, Maryland
    LUNGevity Foundation
Apr 26, 2023

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

Oncology, Chemotherapeutic Toxicity, Metastatic Solid Tumor Trial in Minneapolis (Chemotherapy toxicity tool, Oncology

Active, not recruiting
  • Oncology
  • +2 more
  • Chemotherapy toxicity tool
  • Oncology Consultation
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 30, 2023

Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))

Recruiting
  • Healthy Volunteer
  • REGN7508 (IV)
  • +3 more
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit
Jan 30, 2023

Called RegoFlex EU, to Learn More About Use of Stivarga at

Completed
  • Metastatic Colorectal Cancer
  • Retrospective patient chart review
  • Whippany, New Jersey
    Many locations
Jan 24, 2023

Assess Maternal and Fetal Outcomes After Taking Prucalopride

Recruiting
  • Constipation
  • Pregnancy
    • Boston, Massachusetts
      Harvard T.H. Chan School of Public Health
    Feb 14, 2022

    Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication Trial (mHealth Messaging Intervention Group)

    Not yet recruiting
    • Transplant;Failure,Kidney
    • +4 more
    • mHealth Messaging Intervention Group
    • (no location specified)
    Nov 4, 2022

    Burden of Illness and Treatment Patterns in Teenagers and

    Recruiting
    • Hereditary Angioedema
      • Warszawa, Poland
      • +4 more
      May 6, 2022

      COVID-19 Trial in Canterbury (Sambucol® Black Elderberry Original (Sambucus nigra) Liquid, Placebo for Sambucol® Black

      Completed
      • COVID-19
      • Sambucol® Black Elderberry Original (Sambucus nigra) Liquid
      • Placebo for Sambucol® Black Elderberry Original (Sambucus nigra)
      • Canterbury, Kent, United Kingdom
        East Kent Hospitals University NHS Foundation trust
      Aug 4, 2022

      EHR Precision Drug Treatment in Neonates

      Active, not recruiting
      • Pain, Acute
      • Pain, Chronic
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Jul 7, 2022

        End of Life Trial (Psilocybin-assisted therapy within a community of practice model (group administered))

        Not yet recruiting
        • End of Life
        • Psilocybin-assisted therapy within a community of practice model (group administered)
        • (no location specified)
        Jul 14, 2023

        Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

        Active, not recruiting
        • Neoplasms
        • Carcinoma, Non-Small-Cell Lung
        • BI 754111
        • BI 754091
        • Miami, Florida
        • +14 more
        Jan 9, 2023

        B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

        Not yet recruiting
        • B-cell Non Hodgkin Lymphoma
        • (no location specified)
        Aug 7, 2023

        Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

        Recruiting
        • Relapsing Multiple Sclerosis
        • +2 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • Best Available Therapy (BAT)
        • Palo Alto, California
        • +20 more
        Jan 25, 2023

        Bacteriophage Therapy of Difficult-to-treat Infections

        Completed
        • Bacterial Infections
        • Bacteriophage therapy
        • (no location specified)
        Aug 10, 2022

        Learn About First and Later Lines of Medicines in Treating

        Completed
        • Metastatic Renal Cell Carcinoma
          • New York, New York
            Pfizer Headquarters
          May 12, 2023